OpenEvidence defends its clinical AI against flawed study
The company points out undisclosed conflicts and methodological errors in a competing paper.
See the latest news and media coverage for OpenEvidence. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical evidence platform for clinicians
openevidence.comLast updated
In short: OpenEvidence reached a $12 billion valuation and expanded its AI-powered medical platform through major health system and clinical partnerships.
The company points out undisclosed conflicts and methodological errors in a competing paper.
They integrate GINA’s asthma strategy reports into OpenEvidence alongside peer-reviewed literature for physicians worldwide. Over 300 million people live with asthma.
They integrate ACOG's clinical guidance into OpenEvidence to support ob-gyn care in maternity deserts and develop insights for women's health.
This collaboration enables urologists to access authoritative urologic guidance daily. AUA president praises the strategic AI approach.
Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care...
Los Angeles-based Cedars-Sinai has deployed OpenEvidence systemwide, giving clinicians access to patient-specific medical literature within its EHR. The clinical reference tool links peer-reviewed evidence to...
Jared Perlo / NBC News: OpenEvidence, an AI-powered medical search tool, says it's used by two-thirds of US physicians, or ~650K doctors, and an additional...
Today, the Society of Surgical Oncology (SSO), a global professional society for cancer surgeons, and OpenEvidence, the most widely used medical knowledge platform, announced a...
Track OpenEvidence and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to OpenEvidence and other trending companies.